Caption Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.76M Sell
46,000
-16,500
-26% -$522K 0.01% 861
2025
Q4
$1.36M Buy
+62,500
New +$1.3M 0.01% 954
2025
Q1
Sell
-30,000
Closed -$920K 1508
2024
Q4
$920K Buy
+30,000
New +$997K 0.01% 942
2024
Q3
Sell
-25,000
Closed -$990K 1267
2024
Q2
$990K Buy
+25,000
New +$809K 0.02% 664

Other funds holding ATEX

Caption Management's ATEX Position: Q1 2026 in Review

Caption Management sold out of Anterix (ATEX) in Q1 2026, closing a stake of 10,493 shares — an estimated $332K sold.

Caption Management first reported a position in ATEX in Q3 2022 and held it in 5 quarters. The position peaked at $257K in Q3 2023. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Caption Management reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 10,493 Anterix shares in Q1 2026, an estimated $332K.
  • Caption Management first reported a position in Anterix in Q3 2022 and held it in 5 quarters.
  • Caption Management's Anterix position peaked at $257K in Q3 2023.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.